SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Culper Researchs short report alleging Cerebras wafers may have shorter real-world lifespans and higher operating costs is driving bearish attention, with traders also watching share-unlock supply as a potential source of selling pressure. Bulls dispute the short sellers claims as unverified and point to the Oracle cloud partnership as a counterweight.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS said its Phase 3 REGAL trial of GPS reached the 80th event, triggering final analysis ahead of topline results expected this quarter. Traders are debating the sharp selloff as a sell-the-news reaction versus a warning ahead of the binary data readout; bullish speculation that the trials long duration signals better survival remains unconfirmed.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is drawing attention for a steep selloff to fresh lows, with traders pointing to the companys weak business fundamentals, dilution concerns, and its close association with Trump. Many are bearish and speculate that midterm-election risks could add pressure, while a smaller group sees the decline as a buying opportunity.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Trian and its partners cash proposal to take Wendys private has driven attention and a sharp share move. Traders largely debate whether the bid undervalues the company and will be rejected or raised, while some speculate about a competing offer or short squeeze; no deal has been finalized.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows upcoming quarterly earnings report is the main focus, with traders watching subscription growth, contract momentum, AI monetization and guidance. The pullback has fueled unverified leak rumors and fears of a weak outlook, while others view it as pre-earnings de-risking after a strong run.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Attention centers on a U.S. policy shift that would temporarily let compounding pharmacies produce six peptides, including BPC-157, while regulators review them; traders see potential upside for Hims & Hers but stress that the peptides are not FDA-approved. Many are frustrated that the news has produced only a modest lift and expect shares to remain range-bound near resistance, while skeptics call the moves rumor-driven pumps.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts upcoming quarterly results are the main focus, with traders watching Azure growth, AI spending and whether investment is translating into revenue. The voluntary buyout offer for roughly 60,000 employees adds to the debate: some see cost control to support AI expansion, while others view it as a warning about the buildouts economics; sentiment on the earnings outlook is divided.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The Feds decision to leave rates unchanged despite elevated inflation is driving discussion, with traders weighing the hold against two officials push for a hike and debating whether the outlook points to tighter policy ahead. Reactions describe choppy, largely muted trading and options premium erosion, while bulls and bears disagree on the implications.

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.

Genmab - ADR

Genmabs Phase 3 LiGeR-HN1 trial of petosemtamab plus Keytruda met its primary goals in head and neck cancer, driving a sharp rally and fresh highs on heavy volume. Traders celebrated the data and pipeline prospects, while others cautioned that the stock may be overextended and questioned whether the rally could fade.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientifics earnings report and reduced full-year outlook, including a forecast for lower fourth-quarter sales amid lingering cyberattack disruptions, are driving attention despite a third-quarter revenue beat. Traders are split between viewing the selloff as an overreaction and worrying that operational problems and slowing growth will persist.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HAM Launches Hedgeye Hedged Bitcoin ETF (HBIT) to Help Manage Bitcoin Volatility

HAM Launches Hedgeye Hedged Bitcoin ETF (HBIT) to Help Manage Bitcoin Volatility HAM Launches Hedgeye Hedged Bitcoin ETF (HBIT) to Help Manage Bitcoin Volatility PR Newswire STAMFORD, Conn., Aug. 27, 2026 New actively managed ETF combines bitcoin exposure with a dynamic options strategy driven by...

ETF Opportunities Trust - Hedgeye Hedged Bitcoin ETF

50bps hike

25bps hike

No change

Rate cut

The Federal Reserve announces its rate decision Wednesday, October 28 at 2:00 PM ET, followed by Chair Kevin Warsh’s press conference at 2:30 PM, after raising rates by a quarter point to 3.75%-4.00% in September, its first hike since 2023. What do you think the Fed decides on Wednesday? Vote and explain your reasoning in the comments.

Current Price	$25.90
Prev Close	$25.98
Open	$25.89
Dividend Yield	N/A
50-Day Moving Average	$25.50
Beta	N/A
Avg. Volume	12,118.24
PE Ratio	N/A

52-Week High	$28.22
52-Week Low	$24.25
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

HBIT Fundamentals